Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jazz Pharmaceuticals
Seagen Inc.
Actuate Therapeutics Inc.
Hoffmann-La Roche
Massachusetts General Hospital
Daiichi Sankyo
Boehringer Ingelheim
HealthPartners Institute
Mayo Clinic
Incyte Corporation
Tempus AI
Institut Bergonié
Day One Biopharmaceuticals, Inc.
University of Pittsburgh
Apollomics Inc.
Azienda USL Reggio Emilia - IRCCS
Pfizer
M.D. Anderson Cancer Center
Partner Therapeutics, Inc.
Elevation Oncology
Rain Oncology Inc
Novartis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Zhejiang Provincial People's Hospital
Weill Medical College of Cornell University
Exelixis
Universitair Ziekenhuis Brussel
N.N. Petrov National Medical Research Center of Oncology
pharmaand GmbH
Hoffmann-La Roche
Northwestern University
Istituto Clinico Humanitas
Takeda
Kyunghee University Medical Center
MetiMedi Pharmaceuticals
Cambridge University Hospitals NHS Foundation Trust
Washington University School of Medicine
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Novartis
Memorial Sloan Kettering Cancer Center
Dong-A University Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Alabama at Birmingham
Georgetown University